Literature DB >> 16424507

Resistance to HIV drugs in UK may be lower in some areas.

Julie M Fox, Sarah Fidler, Jonathan Weber.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16424507      PMCID： PMC1336815          DOI： 10.1136/bmj.332.7534.179-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Prevention of mother-to-child transmission of HIV: treatment options.

Authors:  James McIntyre
Journal:  Expert Rev Anti Infect Ther       Date:  2005-12       Impact factor: 5.091

2.  Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Sophie Le Coeur; Chureeratana Bowonwatanuwong; Pacharee Kantipong; Pranee Leechanachai; Surabhon Ariyadej; Prattana Leenasirimakul; Scott Hammer; Marc Lallemant
Journal:  N Engl J Med       Date:  2004-07-09       Impact factor: 91.245

3.  Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997-2000.

Authors:  Iain D Tatt; Katrina L Barlow; Jonathan P Clewley; O Noel Gill; John V Parry
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

4.  Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.

Authors:  Patricia Cane; Ian Chrystie; David Dunn; Barry Evans; Anna Maria Geretti; Hannah Green; Andrew Phillips; Deenan Pillay; Kholoud Porter; Anton Pozniak; Caroline Sabin; Erasmus Smit; Jonathan Weber; Mark Zuckerman
Journal:  BMJ       Date:  2005-11-18
  4 in total
  1 in total

Review 1.  Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.

Authors:  Jorge L Martinez-Cajas; Mark A Wainberg
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.